The Insulin Pumps Market is expected to witness a growth rate of 12% by 2028. Increasing prevalence of diabetes, rising ...

Orchestra BioMed's AVIM earns FDA breakthrough designation, sparking investor optimism. Click here to read why OBIO stock is ...

A federal appeals court panel kept questions to a minimum Tuesday during oral arguments between Medtronic Inc. and the IRS over the best method for pricing the medical device maker’s transactions with ...

"Letter to My Mother" campaign from Medtronic encourages women to have conversations about the risks of heart disease NORTHAMPTON, MA / ACCESS Newswire / May 13, 2025 / The United States is at a ...

The Pacemakers Market is expected to grow at a rate of 3-4% by 2028. The key factors driving the market are the increasing ...

Quantum computing’s role in the medtech space, the impact of Trump’s tariffs on regulation, how AI is reshaping spine surgery ...

The global robotic biopsy devices market is poised for transformative growth, with projections estimating the market ...

Despite having to endure what it called "numerous challenges," Olympus Corporation is reporting a healthy balance sheet as it looks toward the future with a new boss at the helm.

Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the "Company” or "Nexalin”) the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced the reconstitution of its ...

Over 90% of women don't prioritize heart health despite it being the number one killer of women for over a century.FOR MORE INFORMATION: alettertomymother.com ...

As of 2024, the drug device combination products market was dominated by Abbott (US), Boston Scientific Corporation (US), ...